Fetal Monitoring Equipment Market To Reach $6.16 Billion By 2030

 

The global Fetal Monitoring Equipment Market size is anticipated to reach USD 6.16 billion by 2030 and is anticipated to expand at a CAGR of 9.02% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the increasing government initiatives that are aimed at reducing infant mortality rates. Governments are investing heavily in improving healthcare infrastructure, particularly in maternal and neonatal care. Initiatives such as the United Nations Sustainable Development Goals (UNSDGs), specifically targeting a reduction in infant mortality, have prompted government investments in fetal monitoring devices. These programs emphasize improving access to maternal healthcare and advanced medical technologies. In addition, many nations have increased funding for hospitals, clinics, and maternal health centers, often requiring fetal monitoring equipment as a standard feature in obstetric wards. This demand for improved neonatal care, induced by government-backed funding programs.

Moreover, several innovations have emerged, and initiatives are being undertaken, highlighting the potential for more effective monitoring of fetal health. For instance, in September 2023, the RADx Tech Fetal Monitoring Equipment Challenge was launched by the National Institutes of Health (NIH) in partnership with the Bill & Melinda Gates Foundation. The challenge's goal was to speed up the development of diagnostic and monitoring technologies. More than 40 entries was submitted by different innovators, focusing on creating affordable and accessible solutions for monitoring fetal health, especially in low-resource environments.

Furthermore, AI and machine learning are being integrated into fetal monitoring systems to improve data processing and interpretation. These technologies can help in noise suppression, feature detection, & fetal state classification, thereby reducing false positives and enhancing the reliability of monitoring outcomes. For instance, the Lullaby algorithm, developed by researchers at UC Irvine in 2022, effectively distinguishes fetal heartbeats from maternal signals, improving the accuracy of readings.

List of Key Players in the Fetal Monitoring Equipment Market

• Avante Health Solutions
• Bionet America, Inc.
• CooperSurgical Inc. (THE COOPER COMPANIES, INC.)
• EDAN Instruments, Inc.
• FUJIFILM India Private Limited
• GE Healthcare
• Koninklijke Philips NV
• MEDGYN PRODUCTS INC.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Siemens Healthineers
• TRISMED Co., Ltd.

Request a free sample copy or view report summary: Fetal Monitoring Equipment Market Report

Fetal Monitoring Equipment Market Report Highlights

• Based on product, the fetal monitors segment held the largest revenue share in 2023. The growth of this segment is attributed to the growing awareness about the importance of monitoring fetal health, along with an increase in preterm births and fetal issues.
• Based on application, the antepartum segment held the largest revenue share of in 2023. The growing governmental and non-governmental organizations' initiatives aimed at reducing infant mortality rates and improving prenatal care standards have significantly contributed to the expansion of the antepartum segment.
• Based on portability, the non-portable segment held the largest revenue share in 2023. However, portable segment is anticipated to grow at the fastest growth rate over the forecast year.
• Based on type, the non-invasive segment held the largest revenue share of in 2023 and is anticipated to grow at the fastest growth rate over the forecast year.Key drivers contribute to the dominance of non-invasive fetal monitoring.
• Based on end use, the hospitals segment held the largest revenue share of in 2023 and is anticipated to grow at a fastest growth rate over the forecast year.
• North America region held the largest market share in 2023, as companies continuously launching new products and solutions to meet the evolving needs of healthcare providers.

Fetal Monitoring Equipment Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 3.67 billion
Revenue forecast in 2030	USD 6.16 billion
Growth rate	CAGR of 9.02% from 2024 to 2030
Actual data	2018 - 2023
Forecast period	2024 - 2030

Related Press Release@ Fetal Monitoring Equipment Industry Analysis

Fetal Monitoring Equipment Market Segmentation

Grand View Research has segmented the global fetal monitoring equipment market on the basis of product, application, portability, type, end-use, and region:

Fetal Monitoring Equipment Product Outlook (Revenue, USD Million, 2018 - 2030)

• Fetal Monitors
• Fetal Doppler Devices
• Ultrasound Devices
• Fetal Transducer
• Telemetry Devices
• Accessories and Consumables

Fetal Monitoring Equipment Application Outlook (Revenue, USD Million, 2018 - 2030)

• Antepartum
• Intrapartum

Fetal Monitoring Equipment Portability Outlook (Revenue, USD Million, 2018 - 2030)

• Non-Portable
• Portable

Fetal Monitoring Equipment Type Outlook (Revenue, USD Million, 2018 - 2030)

• Non-Invasive
• Invasive

Fetal Monitoring Equipment End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Clinics
• Others

Fetal Monitoring Equipment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Norway
• Denmark
• Sweden
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand 
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Artificial Intelligence In Cardiology Market Size is Predicted to Witness 24.6% CAGR till 2030

 

The global Artificial Intelligence In Cardiology Market size is expected to reach USD 4.8 billion in 2030 and is projected to grow at a CAGR of 24.6% from 2024 to 2030 The increase in the adoption of new technologies by healthcare facilities for the diagnosis and treatment of cardiac diseases, the growing burden of cardiovascular diseases worldwide, and increasing competition among market players to launch new technologies for cardiac imaging are some of the major factors supporting the market's growth.

According to the WHO, cardiovascular diseases are a major cause of death worldwide. The World Heart Federation states that cardiovascular deaths are expected to rise in the coming years. i.e., from 18.9 million in 2020 to 32.3 million in 2050. Some major causes of cardiac diseases are stress, sedentary lifestyles, and an increase in the consumption of fast food, among others. A significant number of people adopting a sedentary lifestyle is expected to increase the disease burden further. This is expected to improve the demand for artificial intelligence (AI) technology to accurately detect cardiac abnormalities and thus boost the market in the post-pandemic period.

Aging is one of the major causes of cardiovascular diseases. According to the National Institute of Health, aging is one of the major reasons for diseases such as coronary artery disease, stroke, heart attack, and other cardiovascular diseases. According to the WHO, in 2020, over 1 billion people were aged 60 years and above, and by 2050, this number is expected to rise to 2.1 billion. The surge in the geriatric population is expected to increase the burden of these diseases and thus support the demand for advanced AI technology in the coming years for treating heart diseases in a better way.

Artificial intelligence has improved and enhanced the accuracy of diagnosing cardiovascular diseases. Machine learning algorithms are increasingly being developed and are widely used in the diagnosis and treatment of heart failure, valvular heart disease, and coronary artery disease, among others. Improved diagnostic and prognostic capabilities using machine learning algorithms are enhancing the clinical care of patients suffering from cardiovascular diseases. Many studies have reported that artificial intelligence detects abnormalities in the heart with more than 80% accuracy. All the above-mentioned factors are likely to boost the demand for AI in cardiology.

List of Key Players in Artificial Intelligence In Cardiology Market

• IDOVEN
• CardiAI
• Ultromics Limited
• Arterys Inc. (Tempus)
• Cardiologs (Koninklijke Philips N.V.)
• Ultrasight
• DiA Imaging Analysis (Koninklijke Philips N.V.)
• Vista AI
• Viz ai
• RSIP Vision
• Cleerly, Inc.

Request a free sample copy or view report summary: Artificial Intelligence In Cardiology Market Report

Artificial Intelligence In Cardiology Market Report Highlights

• Based on component, software segment is expected to grow at the fastest CAGR during the forecast period. AI-based software in cardiology is revolutionizing the field by enhancing diagnostic accuracy, improving patient monitoring, and enabling personalized treatments
• The cardiac arrhythmias segment is expected to grow at the fastest CAGR over the forecast period. Atrial Fibrillation (AF) is one of the most common clinically significant cardiac arrhythmias associated with various cardiovascular complications such as stroke and increased mortality.
• North America dominated the artificial intelligence in cardiology market with a revenue share of over 45.5% in 2023.
• The AI in cardiology market in the Asia Pacific is expected to be driven by the increasing prevalence of cardiovascular diseases in multiple countries, fueling the demand for more efficient and accurate diagnostic & treatment solutions

Artificial Intelligence In Cardiology Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 1.3 billion
Revenue forecast in 2030	USD 4.8 billion
Growth rate	CAGR of 24.6% from 2024 to 2030
Actual data	2018 - 2023
Forecast period	2024 - 2030

 

Artificial Intelligence In Cardiology Market Segmentation

Grand View Research has segmented the global artificial intelligence in cardiology market report based on component, application, medical condition, and region:

Artificial Intelligence In Cardiology Component Outlook (Revenue, USD Million, 2018 - 2030)

• Software
• Hardware
• Services

Artificial Intelligence In Cardiology Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diagnosis
• Prediction
• Drug Discovery
• Others

Artificial Intelligence In Cardiology Medical Condition Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiac Arrhythmias
• Heart Failure
• Ischemic Heart Disease /CAD
• Others

Artificial Intelligence In Cardiology Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Anterior Uveitis Treatment Market Share, Growth and Future Analysis

 The global Anterior Uveitis Treatment Market size is expected to reach USD 967.5 million by 2030, registering a CAGR of 12.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of the disease is anticipated to aid market growth. This disease is more common when compared to panuveitis, posterior, and intermediate uveitis.

According to a 2017 article by Retina Today, this condition accounted for around 30% to 90% of the cases of uveitis. It also stated around 1% to 4% of patients experience 25% loss of visual acuity. There are different effective treatments for this disease and can be easily managed; however, it tends to recur. This disease is prevalent among both young and middle-aged group. It is also common among the geriatric population. Ocular ischemia and herpetic uveitis are the two most common causes of this disease among the geriatric population. Most of the cases occur in healthy people, however, some are associated with infectious diseases, gastrointestinal disorders, rheumatologic diseases, and lung & skin diseases. This disease is less sight-threatening as compared to posterior uveitis, however, in some cases might lead to glaucoma, cataract, and cystoid macular edema.

List Of Key Players Anterior Uveitis Treatment Market

• Novartis AG
• Santen Pharmaceutical Co., Ltd.
• AbbVie Inc.
• Kiora Pharmaceuticals, Inc.
• Clearside Biomedical
• Aldeyra Therapeutics, Inc.
• Aciont Inc.
• Sirion Therapeutics, Inc.
• UCB S.A.
• Lux Biosciences, Inc.
• Tarsier Pharma Ltd.

Request a free sample copy or view report summary: Anterior Uveitis Treatment Market Report

Anterior Uveitis Treatment Market Report Highlights

• Corticosteroids dominated the anterior uveitis treatment market in 2023 owing to its beneficial characteristic of minimizing inflammation in the eye. It is the primary treatment modality.
• Anti-TNF agents are expected to exhibit lucrative growth rate over the forecast period due to growing opportunity in treatment methods with biologic therapy using Anti-TNF drugs.
• Immunosuppressants held a significant market share in 2023 owing to their growing adoption for treatment of chronic anterior uveitis.
• Hospital pharmacies dominated the market in 2023 due to the wide treatment options available there.
• Online pharmacies are expected to witness significant CAGR over the forecast period due to convenience, ease, and availability of discounted products.
• North America held the largest revenue share in 2023 owing to high prevalence as well as healthcare expenditure in this region.
• Asia Pacific is anticipated to exhibit lucrative growth during the forecast period due to the rising number of infectious diseases in developing countries of the region and growing disposable income.

Anterior Uveitis Treatment Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 474.0 million
Revenue forecast in 2030	USD 967.5 million
Growth Rate	CAGR of 12.6% from 2024 to 2030
Base year for estimation	2023
Historical data	2018 - 2022
Forecast period	2024 - 2030

 

Related Press Release@ Anterior Uveitis Treatment Industry Analysis

Anterior Uveitis Treatment Market Segmentation

Grand View Research has segmented the global anterior uveitis treatment market based on type, therapy, distribution channel, and region:

Anterior Uveitis Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)

• Infectious Uveitis
• Non-Infectious Uveitis
• Anterior Uveitis
• Pan-Uveitis
• Posterior Uveitis
• Intermediate  Uveitis

Anterior Uveitis Treatment Therapy Outlook (Revenue, USD Million, 2018 - 2030)

• Corticosteroids
• Immunosuppressive therapies
• Biologics
• Others
• Pipeline Therapies

Anterior Uveitis Treatment Distribution Channel (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Anterior Uveitis Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com